The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002552:Cerebral Ventricles; D002697:Chloral Hydrate / Q000494:pharmacology; D004357:Drug Synergism; D004597:Electroshock; D005260:Female; D005470:Fluorometry; D006591:Hexobarbital / Q000494:pharmacology; D006801:Humans; D007267:Injections; D007545:Isoproterenol / Q000008:administration & dosage* / Q000494:pharmacology; D008124:Locomotion / Q000187:drug effects; D008297:Male; D051381:Rats; D012640:Seizures / Q000517:prevention & control; D012701:Serotonin / Q000378:metabolism; D012890:Sleep / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects; D013997:Time Factors
D012701:Serotonin; D002697:Chloral Hydrate; D006591:Hexobarbital; D000661:Amphetamine; D007545:Isoproterenol